afuresertib

After GSK and Novartis handoffs, Laekna's drug fails ovarian cancer trial
Fierce Biotech
Mon, 01/29/24 - 10:27 pm
Laekna
afuresertib
clinical trials
ovarian cancer
GSK
Novartis
Novartis licenses out unwanted GlaxoSmithKline cancer drugs to Chinese biotech
Fierce Biotech
Wed, 08/1/18 - 11:32 pm
Novartis
China
Laekna
cancer
afuresertib
uprosertib